August 10, 2018
Mölnlycke at IFSO 2018 Dubai
From 26-29 September 2018, Mölnlycke was present at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic...
January 1, 2019
Mölnlycke acquires M&J Airlaid Products A/S to further strengthening its wound care capabilities
Mölnlycke, a world-leading medical products and solutions company, is pleased to announce its acquisition of M&J Airlaid Products A/S (“M&J”).
Thousands of diabetic foot ulcer patients could benefit from topical oxygen therapy with updated treatment pathway
Mölnlycke and Zuellig Pharma strengthen partnership for advanced wound care solutions in South-East Asia
The partnership will leverage deep expertise of both companies to improve range and availability of wound care products and solutions across the region
Mölnlycke acquires patent for smart solutions to detect infection in wounds
The Swedish medical solutions company, Mölnlycke, is acquiring a patent application from Innovation Skåne, that will help detect infections in wounds....
Mölnlycke at the 20th EPUAP Congress: Rome, Italy
In August, Mölnlycke was present at the 20th Annual Meeting of the European Pressure Ulcer Advisory Panel (EPUAP) in Rome, Italy. The congress was held ...
Creating opportunities at AZ BioVenture Hub
Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...
Mölnlycke Holding AB (publ) EUR 350,000,000 Revolving Credit Facility
We are pleased to announce the successful closing and signing of a EUR 350,000,000 Multicurrency Revolving Credit Facility (the “Facility”) for Mölnlyck...
Mölnlycke collaborates with Rochal Industries to strengthen offer in prevention solutions
The Swedish medical solutions company, Mölnlycke Health Care, today (6 December 2016) announced a licensing agreement with the Texas-based biomedical R...